Comorbidities of COVID-19 patients

R Silaghi-Dumitrescu, I Patrascu, M Lehene, I Bercea - Medicina, 2023 - mdpi.com
The novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) responsible
for the coronavirus disease outbreak initiated in 2019 (COVID-19) has been shown to affect …

Comorbidity and its impact on patients with COVID-19

A Sanyaolu, C Okorie, A Marinkovic, R Patidar… - SN comprehensive …, 2020 - Springer
A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2), was identified in Wuhan, China, in December 2019. Since then, the virus has made its …

Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview

A Gupta, H Marzook, F Ahmad - Clinical and experimental medicine, 2023 - Springer
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes major
challenges to the healthcare system. SARS-CoV-2 infection leads to millions of deaths …

Interrelations between COVID-19 and other disorders

A Gasmi, M Peana, L Pivina, S Srinath… - Clinical …, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …

[HTML][HTML] COVID-19 and comorbidities: Deleterious impact on infected patients

H Ejaz, A Alsrhani, A Zafar, H Javed, K Junaid… - Journal of infection and …, 2020 - Elsevier
The pandemic situation with the emergence of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) from China has endangered human lives. Coronavirus …

[HTML][HTML] Comorbidities and severity of coronavirus disease 2019 patients

NM Radwan, NE Mahmoud, AH Alfaifi… - Saudi Medical …, 2020 - ncbi.nlm.nih.gov
Objectives: To determine the association between comorbidities and the severity of the
disease among COVID-19 patients. Methods: We searched the Cochrane, Medline, Trip …

Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature

KT Bajgain, S Badal, BB Bajgain, MJ Santana - American journal of …, 2021 - Elsevier
Introduction On February 11, 2020 WHO designated the name “COVID-19” for the disease
caused by “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus …

[HTML][HTML] Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

J Yang, YA Zheng, X Gou, K Pu, Z Chen, Q Guo… - International journal of …, 2020 - Elsevier
Background An outbreak of coronavirus disease 2019 (COVID-19) occurred in Wuhan,
China; the epidemic is more widespread than initially estimated, with cases now confirmed …

[HTML][HTML] Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis

Y Zhou, Q Yang, J Chi, B Dong, W Lv, L Shen… - International Journal of …, 2020 - Elsevier
Objectives Existing findings regarding the relationship between comorbidities and the
severity of coronavirus disease 2019 (COVID-19) are inconsistent and insufficient. The aim …

[HTML][HTML] COVID-19: Why does disease severity vary among individuals?

S Samadizadeh, M Masoudi, M Rastegar, V Salimi… - Respiratory …, 2021 - Elsevier
The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is
responsible for the current pandemic, coronavirus disease 2019 (COVID-19). While all …